Skyview Financial Group »

Akari Therapeutics Plc Sponsored shares owned by Skyview Financial Group

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Skyview Financial Group from 13F filings

Historical chart of Skyview Financial Group investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Skyview Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Skyview Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.9k 21k 0.29

More positions owned by Skyview Financial Group

Spdr Gold Tr Gold Shs (GLD)
Cardinal Health (CAH)
Boeing Company (BA)
Citigroup Com New (C)
Meta Platforms Cl A (META)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
American Centy Etf Tr Avantis Us Larg (AVLC)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Kla Corp Com New (KLAC)
Thermo Fisher Scientific (TMO)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Aar (AIR)
Uipath Cl A (PATH)
Hca Holdings (HCA)

View all positions for Skyview Financial Group

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Palo Alto Investors
HighTower Advisors
CWA Asset Management
UBS Group
HPM Partners
Virtu Financial
Skyview Financial Group
Two Sigma Securities
Independent Advisor Alliance
Accent Capital Management
Goss Wealth Management
Truvestments Capital
Cornerstone Planning Group

View all funds holding Akari Therapeutics Plc Sponsored